Artificial Intelligence Versus Human-controlled Doctor in Virtual Reality Simulation for Sepsis Team Training

July 17, 2023 updated by: Liaw Sok Ying, National University of Singapore

Artificial Intelligence Versus Human-controlled Doctor in Virtual Reality Simulation for Sepsis Team Training: Randomized Controlled Trial

The purpose of the study is to compare the effectiveness of Artificial Intelligence virtual doctor with human-controlled virtual doctor avatars on nursing students' sepsis care and interprofessional communication.

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

65

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Singapore, Singapore, 117597
        • Alice Lee Centre for Nursing Studies

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  1. All Year 3 NUS nursing students in Academic Year 2022
  2. Individuals 20 years old and above; and
  3. Consent to be video and/or audio-recorded

Exclusion Criteria:

  1. Year 1, 2 and 4 NUS nursing students;
  2. Incapable of giving informed consent;
  3. Unable to understand and/or speak in English language;
  4. Have visual, speech, and/or hearing impairment; and
  5. Do not agree to be video and/or audio-recorded.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: AI-powered group
Participants participated in a 2-hour Virtual Reality Simulation (VRS), which consisted of 2 simulation scenarios. Participants had to perform nursing assessment and management of virtual patient, followed by communicating with an AI virtual doctor.
AI-powered virtual doctor
Active Comparator: Human-controlled group
Participants participated in a 2-hour Virtual Reality Simulation (VRS), which consisted of 2 simulation scenarios. Participants had to perform nursing assessment and management of virtual patient, followed by communicating with a doctor avatar controlled by the medical student.
Virtual doctor avatar controlled by the medical student.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Sepsis Knowledge on the 18-item sepsis knowledge test immediately after interventions.
Time Frame: Baseline and immediately after 2-hour VRS
The 8-item communication knowledge and 18-item sepsis knowledge tests were developed and content validated by a multidisciplinary team comprising a medical doctor, an advanced practice nurse, and nursing academics.
Baseline and immediately after 2-hour VRS

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from Baseline in Team Communication Knowledge on the 8-item communication knowledge test immediately after interventions.
Time Frame: Baseline and immediately after 2-hour VRS
The 8-item communication knowledge and 18-item sepsis knowledge tests were developed and content validated by a multidisciplinary team comprising a medical doctor, an advanced practice nurse, and nursing academics.
Baseline and immediately after 2-hour VRS
Change from Baseline in Team Communication Self-Efficacy on the 6-item Patient Clinical Information Exchange and Interprofessional Communication Self-Efficacy Scale immediately after interventions.
Time Frame: Baseline and immediately after 2-hour VRS
The Patient Clinical Information Exchange and Interprofessional Communication Self-Efficacy Scale is a validated and self-reported instrument using a 0-100 Likert scale, which measures participants' perceptions of self-efficacy in team communication based on the ISBAR communication strategy.
Baseline and immediately after 2-hour VRS
Sepsis Care Performance through a 15-minute video-recorded simulation-based assessment within 2 weeks of postintervention.
Time Frame: Within 2 weeks of postintervention.
2 independent raters used the validated RAPIDS (Rescuing A Patient In Deteriorating Situation) tool to measure nurses' simulation performance in assessing and managing a deteriorating patient.
Within 2 weeks of postintervention.
Team Communication Performance through a 15-minute video-recorded simulation-based assessment within 2 weeks of postintervention.
Time Frame: Within 2 weeks of postintervention.
2 independent raters used a validated 9-item team communication scale to assess nurses' simulation performance in communicating with doctor using the TeamSTEPPS communication strategies.
Within 2 weeks of postintervention.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sok Ying Liaw, National University of Singapore

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 8, 2022

Primary Completion (Actual)

October 26, 2022

Study Completion (Actual)

November 13, 2022

Study Registration Dates

First Submitted

July 10, 2023

First Submitted That Met QC Criteria

July 17, 2023

First Posted (Actual)

July 20, 2023

Study Record Updates

Last Update Posted (Actual)

July 20, 2023

Last Update Submitted That Met QC Criteria

July 17, 2023

Last Verified

July 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

The data sets collected or analyzed during the study are available from the corresponding author on reasonable request.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Sepsis

Clinical Trials on AI-powered doctor

Subscribe